about
A brief review on molecular, genetic and imaging techniques for HCV fibrosis evaluation.A comparison of four fibrosis indexes in chronic HCV: development of new fibrosis-cirrhosis index (FCI)Role of HCV Core gene of genotype 1a and 3a and host gene Cox-2 in HCV-induced pathogenesis.Association of laboratory parameters with viral factors in patients with hepatitis C.Hepatitis C virus to hepatocellular carcinoma.SOCS3 mRNA expression and polymorphisms as pretreatment predictor of response to HCV genotype 3a IFN-based treatment.Interaction of the hepatitis C virus (HCV) core with cellular genes in the development of HCV-induced steatosis.Sequence variability of HCV Core region: important predictors of HCV induced pathogenesis and viral production.Hepatitis C virus p7: molecular function and importance in hepatitis C virus life cycle and potential antiviral target.Dual behavior of HCV Core gene in regulation of apoptosis is important in progression of HCC.Role of different regions of the hepatitis C virus genome in the therapeutic response to interferon-based treatment.Dermatomycoses: challenges and human immune responses.Metachromatic Leukodystrophy (MLD): a Pakistani Family with Novel ARSA Gene Mutation.Role of Toll-Like Receptors in Hepatitis C Virus Pathogenesis and Treatment.PTEN: A potential prognostic marker in virus-induced hepatocellular carcinoma.Anti-apoptotic effect of HCV core gene of genotype 3a in Huh-7 cell lineDown-regulation of IRES containing 5'UTR of HCV genotype 3a using siRNAs.Inhibition of hepatitis C virus genotype 3a by siRNAs targeting envelope genes.Ionotropic Purinergic Receptors P2X4 and P2X7: Proviral or Antiviral? An Insight into P2X Receptor Signaling and Hepatitis C Virus Infection.Disruption of the Reproductive Axis in Freshwater Fish, Catla catla, After Bisphenol-A Exposure.Distribution of IL28B and IL10 polymorphisms as genetic predictors of treatment response in Pakistani HCV genotype 3 patients.Frequency of HLA DQβ1*0201 and DQβ1*0301 Alleles and Total Serum IgE in Patients with Bronchial Asthma: A Pilot Study from Pakistan.Current Status of Direct Acting Antiviral Agents against Hepatitis C Virus Infection in PakistanSerum profile of cytokines and their genetic variants in metabolic syndrome and healthy subjects: a comparative studyAlkaline phosphatase is a predictor of Bone Mineral Density in postmenopausal females.Identification of the deleterious 2080insA BRCA1 mutation in a male renal cell carcinoma patient from a family with multiple cancer diagnoses from PakistanScreening for mutations in two exons of FANCG gene in Pakistani populationModulation of brain kisspeptin expression after bisphenol-A exposure in a teleost fish, Catla catlaAnalysis of toll-like receptors-9 (TLR9) gene polymorphism (rs5743836) in Pakistani patients with HCVMetabolic syndrome: an update on diagnostic criteria, pathogenesis, and genetic linksDifferential Expression of Placental Growth Factor, Transforming Growth Factor-β and Soluble Endoglin in Peripheral Mononuclear Cells in PreeclampsiaAltered expression of vascular endothelial growth factor, vascular endothelial growth factor receptor-1, vascular endothelial growth factor receptor-2, and Soluble Fms-like Tyrosine Kinase-1 in peripheral blood mononuclear cells from normal and preeGenetic Association of Apolipoprotein A5-1131T>C Polymorphism with Traits of Metabolic Syndrome
P50
Q30476922-6A55D486-6BFF-489F-A3F7-CAE5FB01563CQ33877980-492E2BF4-3EB4-48C5-95F3-06907E11330AQ34832969-4C2637D6-7A2F-4CF7-8B92-00D1794AF6E0Q35158444-4FC1496D-122B-4CE3-B314-7F17A3541FD7Q35800315-C0FD8E10-5131-4345-82EC-375006DEAD48Q37358513-0C11AB56-0F82-4B2E-A9BA-DE904AE9742CQ37788976-F655F49D-1C43-46B3-93A2-AE1194379DE5Q37835429-D0E9D105-07BA-484A-81AC-DDD64B26539BQ37860404-4EC0095B-C8A2-4037-9ECA-3A9B9A989AFAQ37977788-904F46A7-A327-4535-99B6-5BCB5D011E69Q38121422-C650DE7A-4C85-4328-B602-D9E36219D699Q38211095-624112F7-7BD9-4F76-8DC7-1E9960A9B305Q38629349-623E643B-18CA-4443-9391-0FAA5B1AD18DQ39026904-55BFB47D-3D44-4EE4-A3C5-E9B8F8C4853CQ39377876-3F1767C1-046E-4987-9BE5-984A42A28572Q39438822-BBF8AF64-22FD-4A1E-975D-327DE275C5D1Q39543313-FD638933-46AD-4EB3-B439-DC0C89078CE6Q39619568-C33F1953-AEFE-4742-BE51-C8BD49B37AD3Q40575385-820A9017-A88E-416F-BE14-621078AA1ADBQ46291248-4F337080-9D3A-4988-A729-C77EC5FFB662Q47552631-EBC8385B-DB75-4DD4-8400-62E0E50A8FDBQ52525485-F61A885F-6E0D-4D06-B202-450AC232F0DEQ58611270-08D87D23-7EC2-4232-920C-2C41CCF8A8F9Q61801773-E89AD33B-CFE9-4CDE-BAA8-E9F2D6E88C10Q64965449-DB7A8A17-6B19-4098-ABAC-BE823E77B6FCQ84549013-C83A6683-82AB-4295-A617-953AB2D280EAQ88338983-FF0D3254-8C4F-4AE1-958A-D7E0F11D0927Q89414482-B1CD8008-27B0-4785-A5FC-E51C3459886EQ90763848-9F63A6E8-8CE3-4265-9746-116CD6A4390CQ91255591-B0CAE727-7D7E-4CE7-BA7E-BE206CCD4736Q92056010-BBB0D9AF-E9A8-4580-B11F-6DC970F872EEQ93088212-A0A6E5E0-C13E-46B1-A7D6-8E0BFA2BCC20Q93112173-C6F752EA-9E1A-41C8-917E-9A8687888EBE
P50
description
researcher
@en
wetenschapper
@nl
հետազոտող
@hy
name
Saba Khaliq
@ast
Saba Khaliq
@en
Saba Khaliq
@es
Saba Khaliq
@nl
type
label
Saba Khaliq
@ast
Saba Khaliq
@en
Saba Khaliq
@es
Saba Khaliq
@nl
prefLabel
Saba Khaliq
@ast
Saba Khaliq
@en
Saba Khaliq
@es
Saba Khaliq
@nl
P106
P1153
34880316300
P31
P496
0000-0002-0345-7394